| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/1997 | US5627067 Monoclonal antibodies cross-reactive and cross-protective against human monoclonal antibodies against pseudomonas aeruginosa serotypes |
| 05/06/1997 | US5627064 Protein kinases |
| 05/06/1997 | US5627055 Finderons and methods of their preparation and use |
| 05/06/1997 | US5627053 2'deoxy-2'-alkylnucleotide containing nucleic acid |
| 05/06/1997 | US5627050 Bone-related sulfatase-like protein and process for its production |
| 05/06/1997 | US5627049 Isolated dna sequence from kluyveromyces |
| 05/06/1997 | US5627043 Production of proteins with dibasic amino acids and cleavage |
| 05/06/1997 | US5627035 Peptides that block human immunodeficiency virus and methods of use thereof |
| 05/06/1997 | US5627023 Enzyme inhibitors for treatment of aids, cell culture and genetic engineerng |
| 05/06/1997 | US5626877 Polymer-based drug delivery system |
| 05/06/1997 | US5626865 Enzyme-orthokeratology |
| 05/06/1997 | US5626863 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 05/06/1997 | US5626862 Drug delivery from polymer matrices by release from matrix by degradation of polymer |
| 05/06/1997 | US5626845 Method to ameliorate osteolysis and metastasis |
| 05/06/1997 | US5626844 Monoclonal antibody against ricin A chain |
| 05/06/1997 | US5626843 Treatment of autoimmune diseases, including AIDS, by removel of interferons, TNFs and receptors therefor |
| 05/06/1997 | US5626841 Use of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosis |
| 05/06/1997 | US5626617 Methods for treating disorders by administering radio frequency signals corresponding to growth factors |
| 05/02/1997 | EP0770876A1 A screening method for identifying ligands for target proteins |
| 05/02/1997 | EP0770681A2 T cell epitopes of the major allergens from ambrosia artemisiifolia |
| 05/02/1997 | EP0770680A2 Lymphocyte-associated cell surface protein |
| 05/02/1997 | EP0770627A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 05/02/1997 | EP0770626A2 Method for purifying thrombomodulin |
| 05/02/1997 | EP0770624A2 Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer |
| 05/02/1997 | EP0770622A2 Cyclic adhesion inhibitors |
| 05/02/1997 | EP0770398A2 Pharmaceutical composition comprising a lens antigen for treatment of cataract |
| 05/02/1997 | EP0770396A2 Use of new factor VIII coagulant polypeptides |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770390A1 Nasally administrable compositions containing physiologically active peptides |
| 05/02/1997 | EP0770389A1 Use of monosialoganglioside GM1 or N-dichloro-acetyl-lyso-GM1 for preventing or reversing neuronal degeneration induced by a long term treatment with L-DOPA in the therapy of Parkinson's disease |
| 05/02/1997 | EP0770141A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2 |
| 05/02/1997 | EP0770140A1 Nucleic acid containing composition, preparation and uses of same |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770135A1 Novel compounds |
| 05/02/1997 | EP0770133A1 Adenovirus comprising a gene coding for an no synthase |
| 05/02/1997 | EP0770132A1 Streptogramines and method for preparing same by mutasynthesis |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0770128A1 Ikaros transgenic cells and animals |
| 05/02/1997 | EP0770094A1 Modified g-protein coupled receptors |
| 05/02/1997 | EP0770093A1 Proteins from mammalian liver and their use in oncology |
| 05/02/1997 | EP0770092A1 $i(HELICOBACTER PYLORI) NICKEL BINDING PROTEIN |
| 05/02/1997 | EP0770091A1 Compounds for reversing drug resistance |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770088A1 Novel cytokine designated lerk-5 |
| 05/02/1997 | EP0770087A1 Human elastase iv |
| 05/02/1997 | EP0770086A1 Macrophage migration inhibitory factor-3 |
| 05/02/1997 | EP0770063A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 05/02/1997 | EP0769968A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 05/02/1997 | EP0769967A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 05/02/1997 | EP0769964A2 Cck antibodies used to improve feed efficiency |
| 05/02/1997 | EP0769962A1 Method of attenuating arterial stenosis |
| 05/02/1997 | EP0769961A1 Attenuation of wound healing processes |
| 05/02/1997 | EP0769960A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
| 05/02/1997 | EP0769959A1 Anti-protozoan methods and materials |
| 05/02/1997 | EP0769958A1 Inhibitors of leukocyte adhesion |
| 05/02/1997 | EP0769957A1 Methods for treating motor deficits |
| 05/02/1997 | EP0769956A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 05/02/1997 | EP0769955A1 Non-antigenic amine derived polymers and polymer conjugates |
| 05/02/1997 | EP0769942A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 05/02/1997 | EP0769932A1 Implanted device containing tumor cells for the treatment of cancer |
| 05/02/1997 | EP0769903A1 Inducible nitric oxide synthase gene for treatment of disease |
| 05/02/1997 | EP0769902A1 Methods for reducing hyperacute rejection of xenografts |
| 05/02/1997 | EP0623024B1 Pharmaceutical bacteriocin compositions and their use for treating gastrointestinal disorders |
| 05/02/1997 | EP0328552B2 Thrombin derived polypeptides, compositions and methods for use |
| 05/01/1997 | WO1997015686A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 05/01/1997 | WO1997015671A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | WO1997015669A1 Chimeric receptor genes and cells transformed therewith |
| 05/01/1997 | WO1997015668A2 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 05/01/1997 | WO1997015667A1 Biologically active eph family ligands |
| 05/01/1997 | WO1997015666A1 Therapeutic antiangiogenic compositions and methods |
| 05/01/1997 | WO1997015663A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 05/01/1997 | WO1997015662A2 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 05/01/1997 | WO1997015661A1 Microporous pathogen-killing composition |
| 05/01/1997 | WO1997015655A2 New artificial tissue, method for the production and the use thereof |
| 05/01/1997 | WO1997015598A1 Novel peptide |
| 05/01/1997 | WO1997015597A1 HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE |
| 05/01/1997 | WO1997015596A1 Human pec-60-like protein and dna encoding the same |
| 05/01/1997 | WO1997015595A1 Method of mobilizing hematopoietic stem cells |
| 05/01/1997 | WO1997015594A1 Novel chemokine for mobilizing stem cells |
| 05/01/1997 | WO1997015593A1 Neurotrophin antagonists |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015591A1 Hemoglobin mutants that reduce heme loss |
| 05/01/1997 | WO1997015590A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 05/01/1997 | WO1997015586A1 Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays |
| 05/01/1997 | WO1997015585A1 Fucose derivatives, drugs containing the same as active ingredient, and intermediates for producing the same |
| 05/01/1997 | WO1997015577A1 Reverse-turn mimetics and methods relating thereto |
| 05/01/1997 | WO1997015574A1 Polymorphic forms of a growth hormone secretagogue |
| 05/01/1997 | WO1997015573A1 Process for the preparation of a growth hormone secretagogue |
| 05/01/1997 | WO1997015572A1 Lubeluzole n-oxide |
| 05/01/1997 | WO1997015553A1 Hyroxamic acid derivatives |
| 05/01/1997 | WO1997015389A1 Preparation of peptide containing biodegradable microspheres by melt process |
| 05/01/1997 | WO1997015330A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | WO1997015327A1 Methods of treating established colitis using antibodies against il-12 |
| 05/01/1997 | WO1997015326A1 Remedy for hepatitides |
| 05/01/1997 | WO1997015324A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | WO1997015323A1 Infusions of neuroprotectants and thrombolytic agents |
| 05/01/1997 | WO1997015322A1 Methods for restoring or enhancing reproductive function in reproductively impaired hosts |
| 05/01/1997 | WO1997015321A1 Pharmaceutical composition containing an activin or inhibin stimulator |
| 05/01/1997 | WO1997015320A1 Novel uses of mammalian ctla-8 and related reagents |
| 05/01/1997 | WO1997015319A1 Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and tgf-beta, optionally in combination with igf-1 |